about
Should Never-Smokers at Increased Risk for Lung Cancer Be Screened?Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening.Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial.Comparative analysis of 5 lung cancer natural history and screening models that reproduce outcomes of the NLST and PLCO trials.Lung cancer detectability by test, histology, stage, and gender: estimates from the NLST and the PLCO trialsPerformance and Cost-Effectiveness of Computed Tomography Lung Cancer Screening Scenarios in a Population-Based Setting: A Microsimulation Modeling Analysis in Ontario, CanadaRisk prediction models for selection of lung cancer screening candidates: A retrospective validation study.Overdiagnosis in lung cancer screening: why modelling is essentialMethods for individualized assessment of absolute risk in case-control studies should be weighted carefully.Risk stratification based on screening history: the NELSON lung cancer screening study.Lung cancer screening: latest developments and unanswered questions.Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening interval.Clarifying Assumptions and Outcomes in Cost-effectiveness Analyses.Baseline Characteristics and Mortality Outcomes of Control Group Participants and Eligible Non-Responders in the NELSON Lung Cancer Screening Study.Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers.Quantifying Overdiagnosis in Cancer Screening: A Systematic Review to Evaluate the Methodology.Low dose CT screening for lung cancer.Re: Think before you leap.Clinically detected non-aggressive lung cancers: implications for overdiagnosis and overtreatment in lung cancer screening.Extrapolation of pre-screening trends: Impact of assumptions on overdiagnosis estimates by mammographic screening.Development and Validation of a Multivariable Lung Cancer Risk Prediction Model That Includes Low-Dose Computed Tomography Screening Results: A Secondary Analysis of Data From the National Lung Screening TrialCost-effectiveness of low-dose CT screening for lung cancer in a European country with high prevalence of smoking-A modelling studyA comparative modeling analysis of risk-based lung cancer screening strategiesPersisting new nodules in incidence rounds of the NELSON CT lung cancer screening studyRisk-Targeted Lung Cancer ScreeningDisparities in Receiving Guideline-Concordant Treatment for Lung Cancer in the United StatesCost-Effectiveness Analysis of Lung Cancer Screening in the United States: A Comparative Modeling StudyTrends in lung cancer risk and screening eligibility affect overdiagnosis estimatesTreatment capacity required for full-scale implementation of lung cancer screening in the United StatesLung cancer screening: enhancing risk stratification and minimising harms by incorporating information from screening resultsAll-cause mortality versus cancer-specific mortality as outcome in cancer screening trials: A review and modeling studyReduced Lung-Cancer Mortality with Volume CT Screening in a Randomized TrialUptake of minimally invasive surgery and stereotactic body radiation therapy for early stage non-small cell lung cancer in the USA: an ecological study of secular trends using the National Cancer Database
P50
Q28386729-820ED491-9DA5-4F3F-A549-309B36DBF165Q30857368-775F7D5A-0AE4-4169-8670-35252E15BA52Q31107011-D78A4706-70DC-4F81-A2EC-0D83E497BFA9Q33651094-C5087F43-6CA8-4227-AD5F-8649630F641FQ35171942-FA8999F7-2AE7-4D1A-943C-35A734BFBACFQ36272784-E78052DF-F29B-421B-965C-BC48D3328959Q36334146-0E9CFC3B-ABE3-4705-9A9A-01B46DFC3056Q37162900-B59F9C3F-35E7-4160-885B-651177D18E47Q37549096-D4186019-6CF6-4A2C-91C9-2323628421C4Q38866240-347A87FD-67A6-4905-AA82-684B6AD4862AQ38947288-F922E0E0-321A-463B-996E-A2A2F1A1A491Q40672861-50828AB7-1A2C-46AA-BE56-1C398FAC183EQ42369390-9AAE15E5-6D8B-476D-AC8F-D367774A6952Q43983680-6E865AE3-E7E0-4F20-8107-EF5E52E0B8D2Q46484976-F31F73FC-BE53-4309-AB29-23CE3C0AFFD0Q47631573-08954B54-A495-4007-BF37-1A988D475DC3Q47668746-9FE09250-8DCC-4D33-A239-8D7898D80894Q48197792-A6109C8E-D118-4FB7-BD04-3A6E3F06DF22Q50026155-2590E8CF-D3D3-4213-9C4C-7BBDE7264067Q53105470-7BA8F745-DB12-43FE-B05A-5B326D173CB9Q64081556-4E23B55A-D18E-4D17-9F9F-14B0B55CDB5BQ88954097-897CA2D8-7AD8-4E24-9659-BA6A6B1EAF78Q90362243-817932DE-CD47-4CFC-8915-6175FE19A242Q90784695-54B4FA75-964F-4CC7-B6E2-FB153A76780BQ90794766-04D73D8C-18EB-416A-9455-692128AE139CQ91040560-97D0D694-89D1-4F17-A390-01AAC2A6ED87Q91092538-9505ECC8-C232-44EF-B4B9-BBEE41D56CC2Q91805058-F8612E49-19B4-4D6E-B0CF-BE01FF4BCE45Q91965343-C96FC924-B5BC-45F1-B7A0-D6D3A771AAD8Q92295447-12F048D3-9AA9-4800-AD4A-39442DD0BAC6Q92679957-C5B2BC7E-C82C-4DF2-ACB1-F9757520D091Q93032481-DA12C3BF-7B2A-474D-8390-B93E8B924B0DQ94669514-BCFAF033-B4F2-443E-9411-606DC52BACC2
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0001-5006-6938
@en
name
Kevin ten Haaf
@ast
Kevin ten Haaf
@en
Kevin ten Haaf
@es
Kevin ten Haaf
@nl
type
label
Kevin ten Haaf
@ast
Kevin ten Haaf
@en
Kevin ten Haaf
@es
Kevin ten Haaf
@nl
prefLabel
Kevin ten Haaf
@ast
Kevin ten Haaf
@en
Kevin ten Haaf
@es
Kevin ten Haaf
@nl
P106
P1153
56047520300
P21
P31
P496
0000-0001-5006-6938